Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1998 Oct;65(4):492–496. doi: 10.1136/jnnp.65.4.492

Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England

N Robertson 1, J Deans 1, D Compston 1
PMCID: PMC2170309  PMID: 9771771

Abstract

OBJECTIVES—To perform a comprehensive survey of myasthenia gravis in the county of Cambridgeshire, England, establishing contemporary epidemiological data.
METHODS—Cases were ascertained from multiple sources. Prevalent patients were visited and assessed by means of a standardised questionnaire and examination complemented by review of medical case notes.
RESULTS—One hundred cases were identified in a population of 684 000 (prevalence 15 per 100 000 population, 95% confidence intervals (95% CIs) 12-18). Thirty eight new diagnoses were made over a five year period providing an incidence of 1.1/100 000 population/year. The sex ratio was 2:1 F:M. After a mean follow up of 11.7 years, symptomatic disease was still restricted to ocular muscles in 25 patients. Thirty four of 100 patients underwent thymectomy a mean of 0.8 years after presentation, and a thymoma was present in 12. Highest remission rates were seen in patients presenting with generalised disease who underwent thymectomy but did not have a thymoma (27%). Cosegregation of an additional autoimmune disease occurred in 27 patients and in 24/49 (49%) women with onset<50 years of age.
CONCLUSIONS—This, the second highest reported prevalence for myasthenia, is likely to be the result of optimum case ascertainment, increased disease duration, application of complex diagnostic tests, and the impact of an aging population leading to a relative increase in the prevalence of ocular myasthenia.



Full Text

The Full Text of this article is available as a PDF (100.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beekman R., Kuks J. B., Oosterhuis H. J. Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J Neurol. 1997 Feb;244(2):112–118. doi: 10.1007/s004150050059. [DOI] [PubMed] [Google Scholar]
  2. FERGUSON F. R., HUTCHINSON E. C., LIVERSEDGE L. A. Myasthenia gravis; results of medical management. Lancet. 1955 Sep 24;269(6891):636–639. doi: 10.1016/s0140-6736(55)92480-6. [DOI] [PubMed] [Google Scholar]
  3. Ferrari G., Lovaste M. G. Epidemiology of myasthenia gravis in the province of Trento (northern Italy). Neuroepidemiology. 1992;11(3):135–142. doi: 10.1159/000110923. [DOI] [PubMed] [Google Scholar]
  4. GARLAND H., CLARK A. N. Myasthenia gravis; a personal study of 60 cases. Br Med J. 1956 Jun 2;1(4978):1259–1262. doi: 10.1136/bmj.1.4978.1259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Giagheddu M., Puggioni G., Sanna G., Tamburini G., Marrosu F., Rachele M. G., Murgia B., Rosati G. Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986). Acta Neurol Scand. 1989 Apr;79(4):326–333. doi: 10.1111/j.1600-0404.1989.tb03793.x. [DOI] [PubMed] [Google Scholar]
  6. Okinaka S., Reese H. H., Katsuki S., Ueki K., Kuroiwa Y., Araki S., Shiraki H., Kurland L. T. The prevalence of multiple sclerosis and other neurological diseases in Japan. Acta Neurol Scand. 1966;42(Suppl):68–76. doi: 10.1111/j.1600-0404.1966.tb02004.x. [DOI] [PubMed] [Google Scholar]
  7. Oosterhuis H. J. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry. 1989 Oct;52(10):1121–1127. doi: 10.1136/jnnp.52.10.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Osserman K. E., Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med. 1971 Nov-Dec;38(6):497–537. [PubMed] [Google Scholar]
  9. Phillips L. H., 2nd, Torner J. C., Anderson M. S., Cox G. M. The epidemiology of myasthenia gravis in central and western Virginia. Neurology. 1992 Oct;42(10):1888–1893. doi: 10.1212/wnl.42.10.1888. [DOI] [PubMed] [Google Scholar]
  10. Phillips L. H., 2nd, Torner J. C. Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology. 1996 Nov;47(5):1233–1238. doi: 10.1212/wnl.47.5.1233. [DOI] [PubMed] [Google Scholar]
  11. Robertson N., Compston A. Surveying multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):2–6. doi: 10.1136/jnnp.58.1.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schon F., Drayson M., Thompson R. A. Myasthenia gravis and elderly people. Age Ageing. 1996 Jan;25(1):56–58. doi: 10.1093/ageing/25.1.56. [DOI] [PubMed] [Google Scholar]
  13. Somnier F. E., Keiding N., Paulson O. B. Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey. Arch Neurol. 1991 Jul;48(7):733–739. doi: 10.1001/archneur.1991.00530190081019. [DOI] [PubMed] [Google Scholar]
  14. Storm-Mathisen A. Epidemiology of myasthenia gravis in Norway. Acta Neurol Scand. 1984 Oct;70(4):274–284. doi: 10.1111/j.1600-0404.1984.tb00825.x. [DOI] [PubMed] [Google Scholar]
  15. Yu Y. L., Hawkins B. R., Ip M. S., Wong V., Woo E. Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurol Scand. 1992 Aug;86(2):113–119. doi: 10.1111/j.1600-0404.1992.tb05050.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES